跳至主要内容
临床试验/NCT03097237
NCT03097237已完成不适用

High Fiber Rye Foods for Weight and Body Fat Reduction

Swedish University of Agricultural Sciences1 个研究点 分布在 1 个国家目标入组 242 人开始时间: 2016年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
242
试验地点
1
主要终点
Difference in body fat mass

研究概览

简要总结

The overall aim of this study is to investigate whether a diet rich in rye fiber from wholegrain rye, compared to refined wheat, as part of a hypocaloric diet leads to larger weight loss and lower body fat content after 12 weeks of intervention. Furthermore the study will investigate the effect on appetite as a potential underlying mechanism for differences in weight loss and body fat reduction.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
30 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • BMI 27-35 kg/m2
  • Hb≥120g/l
  • Serum thyroid stimulating hormone (TSH) ≤4.00 mIU/L
  • Plasma low density lipoprotein cholesterol <5.3 mmol/L
  • Plasma triglycerides ≤1.8 mmol/L
  • Signed informed consent
  • Freezer capacity for 2 weeks bread provision

排除标准

  • Blood donation or participation in a clinical study with blood sampling within 30 days prior to screening visit and throughout the study
  • Unable to complete satisfactorily the 3-day weighted food record at screening visit
  • Unable to lose 0.5 kg or more during the run-in period for men and women not having menstruation during the run in period
  • Increased body weight, despite reported adherence to dietary intake for women with menstruation during the run-in period.
  • Using nicotine products on a daily basis (incl. chewing gum, patches, snus etc.)
  • Using e-cigarettes (regardless of nicotine content)
  • Following any weight reduction program or having followed one during the last 6 months prior to visit 1
  • Diastolic blood pressure 105 mm Hg at visit 1
  • Systolic blood pressure 160 mm at visit 1
  • History of stomach or gastrointestinal conditions (Inflammatory bowel disease, Crohn's disease, malabsorption, colostomy, bowel resection, gastric bypass surgery etc.)
  • More than 10 hours physical activity per week
  • History of heart failure or heart attack within 1 year prior to screening
  • Have type I diabetes
  • Receiving pharmacological treatment for type II diabetes (treatments based on life style interventions are acceptable, as long as they are compatible with the study protocol)
  • Previous gastrointestinal surgery
  • Thyroid disorder
  • History of drug or alcohol abuse
  • Stroke or transient ischemic attack (TIA) within 1 year prior to screening
  • Consumption of drugs aimed at weight management or drugs affecting body weight to a degree that is considered unsuitable for study participation by responsible physician (will be included in the list of allowed/disallowed medications)
  • Pregnant or lactating or wish to become pregnant during the period of the study.
  • Food allergies or intolerances
  • Vegetarian (due to the standardized meals for appetite measurements)
  • Unable to understand written and spoken Swedish
  • Lack of suitability for participation in the trial, for any reason, as judged by the medical doctor or PI.

结局指标

主要结局

Difference in body fat mass

时间窗: 12 weeks

Difference in body weight

时间窗: 12 weeks

次要结局

  • Appetite measured by visual analogue scale (VAS) questionnaire(12 weeks)
  • Fecal energy excretion by bomb calorimetry of 72h quantitative fecal collections.(12 weeks)
  • Gut microbiota(6 and 12 weeks)
  • Marker of Insulin resistance(6 and 12 weeks)
  • Marker of glucose metabolism(6 and 12 weeks)
  • Appetite regulation(6 and 12 weeks)
  • Difference in body weight and body fat mass(6 weeks)
  • Marker of inflammation(6 and 12 weeks)
  • Appetite(6 and 12 weeks)
  • Blood lipids(6 and 12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Rikard Landberg

Professor

Chalmers University of Technology

研究点 (1)

Loading locations...

相似试验